|
Oct 17
|
High Growth Tech Stocks to Watch in October 2024
|
|
Oct 1
|
Catalyst (CPRX) Upgraded to Buy: What Does It Mean for the Stock?
|
|
Oct 1
|
Catalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 2024
|
|
Sep 6
|
Why Is Catalyst (CPRX) Up 8.3% Since Last Earnings Report?
|
|
Sep 2
|
Here's How Much a $1000 Investment in Catalyst Pharmaceutical Made 10 Years Ago Would Be Worth Today
|
|
Jul 24
|
Catalyst Pharmaceuticals Enters Into an Exclusive License, Supply and Commercialization Agreement with Kye Pharmaceuticals for AGAMREE® in Canada
|
|
Jul 22
|
Catalyst Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 7, 2024
|
|
Jun 7
|
Why Is Catalyst (CPRX) Up 0.7% Since Last Earnings Report?
|
|
Jun 7
|
Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock Been Rising: Are Strong Financials Guiding The Market?
|
|
May 30
|
Catalyst Pharmaceuticals Receives U.S. FDA Approval For Increased Maximum Daily Dose For FIRDAPSE®
|
|
May 15
|
2 Incredible Growth Stocks to Buy Hand Over Fist Right Now
|
|
May 8
|
Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update
|
|
May 2
|
Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
|
May 1
|
Catalyst Pharmaceuticals to Participate at the BofA Securities Health Care Conference 2024
|
|
Apr 24
|
Dirt-Cheap Delights: 3 Discounted Stocks That Could Triple by 2026
|
|
Apr 22
|
Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024
|
|
Apr 18
|
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is largely controlled by institutional shareholders who own 65% of the company
|
|
Apr 13
|
Jim Cramer’s 10 Favorite Healthcare Stock Picks in 2024
|
|
Mar 29
|
Why Is Catalyst (CPRX) Down 0.6% Since Last Earnings Report?
|
|
Mar 28
|
Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness Day
|